Publications
5491 Results
- Journal / Conference
- Society of Urologic Oncology (Nov 30, 2022 - Dec 02, 2022, San Diego, CA), poster
- Year
- 2022
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S2011
RANDOMIZED PHASE II TRIAL OF NEOADJUVANT GEMCITABINE, AVELUMAB AND CARBOPLATIN VS. NO NEOADJUVANT THERAPY PRECEDING SURGERY FOR CISPLATIN-INELIGIBLE MUSCLE-INVASIVE UROTHELIAL CARCINOMA (MIUC): SWOG GAP TRIAL (S2011)
- Journal / Conference
- ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), oral
- Year
- 2022
- Research Committee(s)
- Cancer Survivorship
A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of ECOG-ACRIN EA9131
- Journal / Conference
- ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), poster
- Year
- 2022
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, SWOG-9031, SWOG-9333
A Robust Long Non-Coding RNA Expression Classifier for Risk Stratification in Pediatric AML
- Journal / Conference
- ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), poster
- Year
- 2022
- Research Committee(s)
- Myeloma
- Study Number(s)
- S1304
Renal Toxicity with Carfilzomib in Multiple Myeloma: Secondary Analysis of SWOGS1304 Comparing Low-Dose Versus High-Dose Carfilzomib
- Journal / Conference
- Melanoma Bridge Meeting (Dec 1-3.2-22, Napoli, Italy), oral
- Year
- 2022
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1801
EXPLORATORY ANALYSES FROM SWOG S1801
- Journal / Conference
- ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), poster
- Year
- 2022
- Research Committee(s)
- Leukemia
Umbrella Trial in Myeloid Malignancies: the myeloMATCH National Clinical Trials Network Precision Medicine Initiative
- Journal / Conference
- Supportive Care in Cancer Dec 31;31(1):93
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36585488
- PMC
- PMC9803880
- Study Number(s)
- S1204
Antiviral Therapy Use and Related Outcomes in Patients with Cancer and Viral Infections: Results from SWOG S1204
- Journal / Conference
- Nature Communications Sep 19;13(1):5478
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36117191
- PMC
- PMC9482920
- Study Number(s)
- CTSU/C80405
ARID1A mutations induce an EGFR-like signature and confer intrinsic and acquired resistance to cetuximab treatment in colon cancer
- Journal / Conference
- Bladder Cancer, volume 8; issue 4
- Year
- 2022
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0337
Paper Alert—Implementing a New Standard of Care [Commentary]
- Journal / Conference
- JAMA Network Open Nov 1;5(11):e2241720
- Year
- 2022
- Research Committee(s)
- Symptom Control and Quality of Life
- PMID
- PMID36367721
- PMC
- PMC9652759
- Study Number(s)
- S1200